Latham, Goodwin Lead 2 Biotech IPOs Raising $227M
Venture-backed biotechnology companies Kiniksa Pharmaceuticals Ltd. and Scholar Rock Holding Corp. debuted in public markets Thursday to strong investor receptions after completing initial public offerings that raised a combined $227 million,...To view the full article, register now.
Already a subscriber? Click here to view full article